Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

INHALED NITRIC-OXIDE IN ANESTHESIA AND CRITICAL CARE MEDICINE INTERNATIONAL ANESTHESIOLOGY CLINICS Kavanagh, B. P., Pearl, R. G. 1995; 33 (1): 181-210

Abstract

Inhaled NO is an exciting new drug and has enormous potential in the therapy of a wide variety of acute, and possibly chronic, cardiopulmonary disorders. No reports of controlled, randomized, and blinded trials have been published concerning the use of inhaled NO in any clinical condition. In the United States, use of inhaled NO currently requires an investigational new drug approval from the Food and Drug Administration. Physicians involved in anesthesia and critical care medicine have a unique opportunity to validate a new mode of therapy in acute care, and optimal evaluation should be undertaken so that the real therapeutic role of inhaled NO may be defined.

View details for Web of Science ID A1995QX08000011

View details for PubMedID 7635555